BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 11895345)

  • 1. Genetic susceptibility in Dupuytren's disease: lack of association of a novel transforming growth factor beta(2) polymorphism in Dupuytren's disease.
    Bayat A; Alansar A; Hajeer AH; Shah M; Watson JS; Stanley JK; Ferguson MW; Ollier WE
    J Hand Surg Br; 2002 Feb; 27(1):47-9. PubMed ID: 11895345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic susceptibility in Dupuytren's disease. TGF-beta1 polymorphisms and Dupuytren's disease.
    Bayat A; Watson JS; Stanley JK; Alansari A; Shah M; Ferguson MW; Ollier WE
    J Bone Joint Surg Br; 2002 Mar; 84(2):211-5. PubMed ID: 11924651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic susceptibility to Dupuytren's disease: transforming growth factor beta receptor (TGFbetaR) gene polymorphisms and Dupuytren's disease.
    Bayat A; Stanley JK; Watson JS; Ferguson MW; Ollier WE
    Br J Plast Surg; 2003 Jun; 56(4):328-33. PubMed ID: 12873459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene expression analysis of Dupuytren's disease: the role of TGF-beta2.
    Zhang AY; Fong KD; Pham H; Nacamuli RP; Longaker MT; Chang J
    J Hand Surg Eur Vol; 2008 Dec; 33(6):783-90. PubMed ID: 18694919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia.
    Kuhn MA; Wang X; Payne WG; Ko F; Robson MC
    J Surg Res; 2002 Apr; 103(2):146-52. PubMed ID: 11922728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of a novel gene, MafB, in Dupuytren's disease.
    Lee LC; Zhang AY; Chong AK; Pham H; Longaker MT; Chang J
    J Hand Surg Am; 2006 Feb; 31(2):211-8. PubMed ID: 16473681
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is Dupuytren's disease caused by an imbalance between proliferation and cell death?
    Jemec B; Grobbelaar AO; Wilson GD; Smith PJ; Sanders R; McGrouther DA
    J Hand Surg Br; 1999 Oct; 24(5):511-4. PubMed ID: 10597921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta: possible roles in Dupuytren's contracture.
    Kloen P; Jennings CL; Gebhardt MC; Springfield DS; Mankin HJ
    J Hand Surg Am; 1995 Jan; 20(1):101-8. PubMed ID: 7722248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of transforming growth factor-beta1 gene polymorphism with familial vesicoureteral reflux.
    Kuroda S; Solari V; Puri P
    J Urol; 2007 Oct; 178(4 Pt 2):1650-3. PubMed ID: 17707032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic susceptibility to keloid disease: transforming growth factor beta receptor gene polymorphisms are not associated with keloid disease.
    Bayat A; Bock O; Mrowietz U; Ollier WE; Ferguson MW
    Exp Dermatol; 2004 Feb; 13(2):120-4. PubMed ID: 15009106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokine manipulation of explanted Dupuytren's affected human palmar fascia.
    Kuhn MA; Payne WG; Kierney PC; Pu LL; Smith PD; Siegler K; Ko F; Wang X; Robson MC
    Int J Surg Investig; 2001; 2(6):443-56. PubMed ID: 12678125
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of association of iron metabolism and Dupuytren's disease.
    Hnanicek J; Cimburova M; Putova I; Svoboda S; Stritesky J; Kratka K; Sosna B; Horak J
    J Eur Acad Dermatol Venereol; 2008 Apr; 22(4):476-80. PubMed ID: 18194242
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The heritability of Dupuytren's disease: familial aggregation and its clinical significance.
    Hindocha S; John S; Stanley JK; Watson SJ; Bayat A
    J Hand Surg Am; 2006 Feb; 31(2):204-10. PubMed ID: 16473680
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beta-catenin overexpression in Dupuytren's disease is unrelated to disease recurrence.
    Degreef I; De Smet L; Sciot R; Cassiman JJ; Tejpar S
    Clin Orthop Relat Res; 2009 Mar; 467(3):838-45. PubMed ID: 18958538
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Common variants of the EPDR1 gene and the risk of Dupuytren’s disease.
    Dębniak T; Żyluk A; Puchalski P; Serrano-Fernandez P
    Handchir Mikrochir Plast Chir; 2013 Oct; 45(5):253-7. PubMed ID: 24089297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case-control study of childhood acute lymphoblastic leukaemia and polymorphisms in the TGF-beta and receptor genes.
    Dai L; Gast A; Horska A; Schrappe M; Bartram CR; Hemminki K; Kumar R; Bermejo JL
    Pediatr Blood Cancer; 2009 Jul; 52(7):819-23. PubMed ID: 19229971
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic susceptibility to dupuytren disease: association of Zf9 transcription factor gene.
    Bayat A; Watson JS; Stanley JK; Ferguson MW; Ollier WE
    Plast Reconstr Surg; 2003 Jun; 111(7):2133-9. PubMed ID: 12794452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sibling recurrence risk in Dupuytren's disease.
    Capstick R; Bragg T; Giele H; Furniss D
    J Hand Surg Eur Vol; 2013 May; 38(4):424-9. PubMed ID: 22791609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of limited joint mobility with Dupuytren's contracture in diabetes mellitus.
    Pal B; Griffiths ID; Anderson J; Dick WC
    J Rheumatol; 1987 Jun; 14(3):582-5. PubMed ID: 3305932
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Genetic aspect of Dupuytren's diseases].
    Bobiński R; Olczyk K; Wisowski G; Janusz W
    Wiad Lek; 2004; 57(1-2):59-62. PubMed ID: 15181751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.